Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marrow transplantation: the Seattle experience.

R Storb

    The Tokai Journal of Experimental and Clinical Medicine
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Hematopoietic stem cell transplantation offers significant long-term survival for aplastic anemia and certain leukemias. This therapy provides cures for some genetic disorders and is being explored for various cancers.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1992
    Same author

    Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.

    Transplantation·1992
    Same author

    Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.

    Transplantation·1992
    Same author

    Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.

    Transplantation·1992
    Same author

    Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules.

    Blood·1992
    Same author

    Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.

    Blood·1992
    Same journal

    Dengue Fever Complicated by Acute Acalculous Cholecystitis and Hemophagocytic Lymphohistiocytosis Despite Negative PCR.

    The Tokai journal of experimental and clinical medicine·2026
    Same journal

    Carbamazepine-Induced Drug-Induced Hypersensitivity Syndrome With Primary Adrenal Insufficiency: A Case Report.

    The Tokai journal of experimental and clinical medicine·2026
    Same journal

    Electrocautery-Assisted Pleural Puncture for a Highly Reproducible Rat Pneumothorax Model.

    The Tokai journal of experimental and clinical medicine·2026
    Same journal

    Effect of a Reduced Frame Rate for Videofluoroscopic Swallowing Studies on the Recognition of Aspiration in Adult Patients.

    The Tokai journal of experimental and clinical medicine·2026
    Same journal

    Successful Engraftment After Repeat Cord Blood Transplantation Using an Identical Conditioning Regimen for MPS II.

    The Tokai journal of experimental and clinical medicine·2026
    Same journal

    Accuracy of Kampo Diagnostic Support System: Comparison With Certified Physicians of the Japan Society for Oriental Medicine.

    The Tokai journal of experimental and clinical medicine·2026
    See all related articles

    Area of Science:

    • Hematology
    • Immunology
    • Oncology

    Background:

    • Hematopoietic stem cell transplantation (HSCT) is a crucial treatment for specific hematological diseases.
    • Patient eligibility often requires being under 50 with an HLA-identical sibling donor.

    Purpose of the Study:

    • To review the efficacy of marrow transplantation for various hematological diseases.
    • To highlight its role in treating genetic disorders and its emerging applications in cancer therapy.

    Main Methods:

    • Review of existing data on marrow transplantation outcomes.
    • Analysis of survival rates and cure probabilities for different conditions.

    Main Results:

    • High survival rates (70-85%) for aplastic anemia.

    Related Experiment Videos

  • Variable cure rates (10-60%) for acute and chronic leukemias depending on disease phase and remission status.
  • Successful treatment of inherited immunologic and genetic storage diseases.
  • Exploration of HSCT for lymphomas, multiple myeloma, and solid tumors.

    • Conclusions:

    • Marrow transplantation is a life-saving treatment for aplastic anemia and select leukemias.
    • It offers potential cures for certain genetic disorders.
    • Expanding donor sources (HLA-nonidentical, unrelated) are improving accessibility.